The COVID-19 pandemic has shown that pandemic preparedness and response require coordinated and strategic efforts. From the outset, it is crucial to monitor, steer, and proactively support the implementation of such complex processes.
In order to be prepared and ready to act during future pandemics with respect to personnel, expertise, and technology, ZEPAI establishes an interdisciplinary pool of experts. The team will cover the entire spectrum of pandemic-relevant activities, including drug manufacturing, logistics, infectiology, law, communication and public health services.
ZEPAI's work focuses on four central fields of action:
ZEPAI ensures that vaccine manufacturing capacities (facilities, personnel, raw materials, technical consumables) are available at all times and secures the supply chains for all critical supplier products.
ZEPAI assumes both an operative and a monitoring function pertaining to the nationwide distribution of pandemic vaccines. ZEPAI also organizes and monitors the procurement, storage, and, if applicable, the distribution of pandemic therapeutics. Using digital data collection and monitoring structures, the procurement and distribution of vaccines will be efficient, targeted and sustainable.
In order to develop vaccines and therapeutics for a pandemic and to produce and distribute them rapidly in the event of a pandemic, permanent networking of all stakeholders is required. To this end, ZEPAI will ensure reliable communication channels with national and international stakeholders. ZEPAI aims to initiate and sustainably establish strategic collaborations with pandemic-relevant public institutions and private companies at both national and international levels.
ZEPAI keeps track of science and technology for the further development of pandemic preparedness, including novel application forms and manufacturing technologies, and developes pandemic preparedness concepts for vaccines and therapeutics.
Updated: 14.06.2024
